- Home
- JG vs ERNA Comparison
JG vs ERNA Comparison
Compare JG & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JG | ERNA |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 10.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | JG | ERNA |
|---|---|---|
| Price | $6.25 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.2K | ★ 43.7K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $50,967,244.00 | $1,000.00 |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.78 | N/A |
| 52 Week Low | $5.75 | $1.08 |
| 52 Week High | $20.94 | $14.40 |
Technical Indicators
Market Signals| Indicator | JG | ERNA |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 41.30 |
| Support Level | $6.16 | $1.08 |
| Resistance Level | $6.60 | $1.29 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 17.69 | 23.08 |
Price Performance
Historical ComparisonAbout JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.